MEDIPOST Obtains Patent in China for its Alzheimer’s Disease Treatment Substance2016/04/06STEM CELL THERAPEUTIC
MEDIPOST Obtains Patent in Canada for its ‘PNEUMOSTEM’ Used to Treat Lung Diseases2016/03/10STEM CELL THERAPEUTIC
MEDIPOST Obtains Stem Cell Therapy Patent in Japan for Treating Alzheimer’s Disease2016/01/13STEM CELL THERAPEUTIC
Singapore/Taiwan consecutively invited MEDIPOST to its stem cell forums2015/11/19STEM CELL THERAPEUTIC
‘PNEUMOSTEM’ selected as the ‘Newly developed and promising medical technology’ by National evidence based healthcare collaborating agency2015/11/02STEM CELL THERAPEUTIC
Selected as a conducting company of ‘global high-tech biomedicine industry’2015/10/26STEM CELL THERAPEUTIC
MEDIPOST announced extension plans in US ’2015 Stem Cell Meeting on the Mesa’2015/10/07STEM CELL THERAPEUTIC
US ‘Stem cells regenerative medicine congress’ invites MEDIPOST for the first time as a Korean company2015/09/02STEM CELL THERAPEUTIC
MEDIPOST, achieves ‘150 patent applications and 50 patent registrations’2015/08/27STEM CELL THERAPEUTIC
Core dementia treatment technology patented at 6 European countries, concurrently2015/07/30STEM CELL THERAPEUTIC
‘CARTISTEM’ shows superb results from 3 year long term tracking clinical trials2015/07/23STEM CELL THERAPEUTIC
